U-Systems’ somo •v Automated Breast Ultrasound (ABUS) system is approved for use in combination with mammography for women with dense breast tissue.
The FDA has approved an automated breast ultrasound system for use in combination with mammography for women with dense breast tissue.
U-Systems’ somo•v Automated Breast Ultrasound (ABUS) system is the only approved ultrasound device designed especially for screening women with dense breast tissue who have negative mammograms and no symptoms of disease, the FDA said. These women must also have no previous history of clinical breast intervention.
Ultrasound breast imaging uses a transducer to direct high-frequency sound waves throughout the breast. The uniquely-shaped somo•v Automated Breast Ultrasound system transducer scans the entire breast in approximately one minute and produces several images.
The FDA reviewed clinical study results that asked board-certified radiologists to analyze mammograms alone or along with somo•v ABUS images. The agency reviewed image interpretations from 200 women with dense breasts and negative mammograms.
Masses detected through somo•v ABUS were biopsied, and results revealed a statistically significant increase in breast cancer detection when ABUS images are analyzed alongside mammograms.
Included in the device’s approval, the agency is mandating U-Systems properly train physicians and technologists in using the ABUS transducer, as well as provide each facility with a manual that details the system tests necessary for initial, periodic, and yearly quality-control measures.
Previous research published in the journal European Radiology revealed breast cancer detection doubled among study participants when ABUS was used with mammography. Detection rates also tripled for cancers smaller than 10 mm.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.